CX3CL1 and breast carcinoma: FKN overexpression in humanized tumor mice, which show human tumors and the human immune system, resulted in the enhanced efficacy of trastuzumab treatment, especially for preventing lung metastases composed of FKN-overexpressing breast cancer cells [347].